Order the first TXAI authored book. Click here for details.

Information and photographs of our last Health Fair are now available! Click here to visit our Health Fair information.

Papers published from the
Texas Arrhythmia Institute

Pacifico A and Henry PD: Ablation for Atrial Fibrillation: Are Cures Really Achieved? JACC, 2004;43;1940-1943

Pacifico A and Henry PD: Class I or Class III Agents for Atrial Fibrillation: Are we Asking the Right Question? PACE, 2003;26:1-8

Pacifico A and Henry PD: Structural Pathways and Prevention of Heart Failure and Sudden Death. J Cardiovasc Electrophysiol, 2003;14:1-12

Bailin SJ, Niebauer M, Tomassoni G, Leman R, and the Photon Investigators: Clinical Investigation of a New Dual-Chamber Implantable Cardioverter Defibrillator with Improved Rhythm Discrimination Capabilities. J Cardiovasc Electrophysiol, 2003;14:144

Herre JM, Sung RJ, Daubert JP, Greene HL, Hofer BO, Klevan LR, Kron J, Larsen GC, Marinchak RA, Pacifico A, Page RL, Schwartz KM, Shih T, Moore R, Hallstrom AP and the AVID Investigators: Changing Practice of Surgery for the Implantable Cardioverter Defibrillator. (In Press)

Klein RC, Raitt MH, Wilkoff BL, Beckman KJ, Coromilas J, Wyse DG, Friedman PL, Martins JB, Epstein AE, Engelstein ED, Kim SG, Pacifico A, Belco KM, Steinberg JS, Lancaster S, Greene HL and the AVID Investigators: Analysis of Implantable Cardioverter Defibrillator Therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. JACC (In Press)

Shih H-T, Wyse DG, Rizo-Patron C, Stamato NJ, Daubert JP, Lancaster S, Renfroe EG, Connors N, Pacifico A, Crevey B, Jennings C, Whiting, Hallstrom AP and the AVID Investigators: Regional Differences in Utilization of Implantable Cardioverter/Defibrillators- An Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry Study. (In Press)

Bailin SJ, Niebauer M, Tomassoni G, Leman R, and the Photon Investigators: Clinical Investigation of a New Dual-Chamber Implantable Cardioverter Defibrillator with Improved Rhythm Discrimination Capabilities. J Cardiovasc Electrophysiol, 2003;14:144.

Renfroe EG, Heywood G, Foreman L, Schron E, Powell J, Baessler C, Warwick D, Morris M, Hallstrom A for the AVID Coordinators and Investigators: The end-of-study patient survey: Methods influencing response rate in the AVID trial. Controlled Clinical Trials, 2002;23:521-533.

Brodsky MA, Mitchell LB, Halperin BD, Raitt MH, Hallstrom AP and the AVID Investigators: Prognostic value of baseline electrophysiology studies in patients with sustained ventricular tachyarrhythmias: The antiarrhythmics versus implantable defibrillators (AVID) trial. Am Heart J, 2002;144:478-484.

Cook JR, Rizo-Patron C, Curtis AB, Gillis AM, Bigger JT Jr, Kutalek SP, Coromilas J, Hoter BL, Powell J, Hallstrom AP for the AVID Investigators: Effect of surgical revascularization in patients with coronary artery disease and ventricular tachycardia or fibrillation in the antiarrhythmics versus implantable defibrillators (AVID) registry. Am Heart J, 2002;143:821-826.

Larsen G, Hallstrom A, McAnulty J, Pinski S, Olarte A, Sullivan S, Brodsky M, Powell J, Marchant C, Jennings C, Akiyama T and the AVID Investigators: Cost-effectiveness of the implantable cardioverter-defibrillator versus antiarrhythmic drugs in survivors of serious ventricular tachyarrhythmias: Results of the antiarrhythmics versus implantable defibrillators (AVID) economic analysis substudy. Circulation, 2002;105:2049-2057.

Pacifico A: Review of Ellenbogen KA, Kay GN and Wilkoff BL, eds., Clinical Cardiac Pacing and Defibrillation, 2nd Edition. Circulation, 2002;105:1273.

Fink P, Arndt GD, Carl JR, Beer R, Raffoul G, Pacifico A, and Henry P: Millimeter-Wave and Microwave Treatment of Atherosclerosis. NASA Tech Briefs, 2002;26:42-43.

Schron EB, Exner DV, Yao Q, Jenkins LS, Steinberg JS, Cook JR, Kutalek SP, Friedman PL, Bubien RS, Page RL, Powell J and the AVID Investigators: Quality of Life in the Antiarrhythmics Versus Implantable Defibrillators Trial. Circulation, 2002;105:589-594.

Wyse DG, Friedman PL, Brodsky MA, Beckman KJ, Carlson MD, Curtis AB, Hallstrom AP, Raitt MH, Wilkoff BL, Greene HL for the AVID Investigators: Life-Threatening Ventricular Arrhythmias Due to Transient or Correctable Causes: High Risk for Death in Follow-Up. J Am Coll Cardiol, 2001;38:1718-1724.

Wyse DG, Love JC, Yao Q, Carlson MD, Cassidy P, Greene HL, Martins JB, Ocampo C, Raitt MH, Schron E, Stamato NJ, Olarte A and the AVID Investigators: Atrial Fibrillation: A Risk Factor for Increased Mortality--An AVID Registry Analysis. J Interventional Cardiac, Electrophysiology 2001;5:267-273.

Ehlert FA, Cannom DS, Renfroe EG, Green HL, Ledingham R, Mitchell LB, Anderson JL, Halperin BD, Herre JM, Luceri RM, Marinchak RA, Steinberg JS and the AVID Investigators: Comparison of dilated cardiomyopathy and coronary artery disease in patients with life- threatening ventricular arrhythmias: Differences in presentation and outcome in the AVID registry. Am Heart J, 2001;142:816-822.

Steinberg JS, Martins J, Sadanandan S, Goldner B, Menchavez E, Domanski M, Russo A, Tullo N, Hallstrom AP and the AVID Investigators: Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study. Am Heart J, 2001;142:520-529.

Steinberg JS, Beckman K, Greene HL, Marinchak R, Klein RC, Greer SG, Ehlert F, Foster P, Menchavez E, Raitt M, Wathen MS, Morris M, Hallstrom AP and the Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators: Follow-up of Patients with Unexplained Syncope and Inducible Ventricular Tachyarrhythmias: Analysis of the AVID Registry and an AVID Substudy. J Cardiovasc Electrophysiol, 2001;12:996-1001.

Hallstrom AP, Greene HL, Wilkoff BL, Zipes DP, Schron E, Ledingham RB and the Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators: Relationship Between Rehospitalization and Future Death in Patients Treated for Potentially Lethal Arrhythmia. J Cardiovasc Electrophysiol, 2001;12:990-995.

Friedman PA, Dijkman B, Warman EN, Zia A, Mehra R, Stanton MS, Hammill SC for the Worldwide Jewel SF Investigators: Atrial Therapies Reduce Atrial Arrhythmia Burden in Defibrillator Patients. Circulation, 2001;104:1023-1028.

Adler SW II, Wolpert C, Warman EN, Musley SK, Koehler JL, Euler DE for the Worldwide Jewel SF Investigators: Efficacy of Pacing Therapies for Treating Atrial Tachyarrhythmias in Patients With Ventricular Arrhythmias Receiving a Dual-Chamber Implantable Cardioverter Defibrillator. Circulation, 2001; 104:887-892.

Akiyama T, Powell JL, Mitchell LB, Ehlert FA and Baessler C for the Antiarrhythmics versus Implantable Defibrillators Investigators: Resumption of Driving after Life-Threatening Ventricular Tachyarrhythmia. N Eng J Med, 2001;345:391-397.

Hickey K, Curtis AB, Lancaster S, Larsen G, Warwick D, McAnulty J, Mitchell BL and the AVID Investigators: Baseline factors predicting early resumption of driving after life-threatening arrhythmias in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. Am Heart J, 2001;142:99-104.

Schoels W, Swerdlow CD, Jung W, Stein KM, Seidl K, Haffajee CJ for the Worldwide Jewel AF Investigators: Worldwide Clinical Experience with a New Dual-Chamber Implantable Cardioverter Defibrillator System. J Cardiovasc Electrophysiol, 2001;12:521-528.

Exner DV, Sheldon RS, Pinski SL, Kron J, Hallstrom A and the AVID Investigators: Do baseline characteristics accurately discriminate between patients likely versus unlikely to benefit from implantable defibrillator therapy? Am Heart J, 2001;141:99-104.

Kron J, Herre J, Renfroe EG, Rizo-Patron C, Raitt M, Halperin B, Gold M, Goldner B, Wathen M, Wilkoff B, Olarte A, Yao Q and the AVID Investigators: Lead- and Device-Related Complications in the Antiarrhythmics Versus Implantable Defibrillators Trial. Am Heart J, 2001;141:92-98.

Hallstrom AP, McAnulty JH, Wilkoff BL, Follman D, Raitt MH, Carlson MD, Gillis AM, Shih H-T, Powell JL, Duff H, Halperin BD and the Antiarrhvthmics Versus Implantable Defibrillator (AVID) Trial Investigators: Patients at Lower Risk of Arrhythmia Recurrence: A Subgroup in Whom Implantable Defibrillators May Not Offer Benefit. J Am Coll Cardiol, 2001;37:1093-1099.

Exner DV, Pinski SL, Wyse G, Renfroe EG, Follmann D, Gold M, Beckman KJ, Coromilas J, Lancaster S, Hallstrom AP and the AVID Investigators: Electrical Storm Presages Nonsudden Death: The Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. Circulation, 2001;103:2066-2071.

Raitt MH, Renfroe EG, Epstein AE, McAnulty JH, Mounsey P, Steinberg JS, Lancaster SE, Jadonath RL, Hallstrom AP for the AVID Investigators: "Stable" Ventricular Tachycardia Is Not a Benign Rhythm: Insights from the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry. Circulation, 2001;103:244-252.

Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuch K-H, Zipes DP, Greene HL, Boczor S, Domanski M, Follman D, Gent M, Roberts RS on behalf of the Investigators of the AVID, CASH and CIDS studies: Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. Eur Heart J, 2000;21:2071-2078.

Pacifico A and Henry PD: Ablation to Treat Atrial Fibrillation: First Choice Therapy? (In Press)

Ellenbogen KA, Edel T, Moore S, Higgins S, Pacifico A, Wilber D, Wood MA, Rogers R, Dahn A, Zhu A and The Ventak AV II DR Study Investigators: A Prospective Randomized-Controlled Trial of Ventricular Fibrillation Detection Time in a DDDR Ventricular Defibrillator. PACE, 2000;23:1268-1272.

Pinski SL, Yao Q, Epstein AE, Lancaster S, Greene HL, Pacifico A, Cook JR, Jadonath R, Marinchak RA and the AVID Investigators: Determinants of outcome in patients with sustained ventricular tachyarrhythmias: The Antiarrhythmics Versus Implantable Defibrillators (AVID) Study. Am Heart J, 2000;193:804-813.

The AVID Investigators: Causes of Death in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. JACC, 1999;34:1552-1559.

Epstein AE, Powell J, Yao Q, Ocampo C, Lancaster S, Rosenberg Y, Cannom DS, Herre JM, Greene HL, and the AVID Investigators: In-Hospital Versus Out-of-Hospital Presentation of Life- Threatening Ventricular Arrhythmias Predicts Survival: Results from the AVID Registry. JACC, 1999;34:1111-1116.

Exner DV, Reiffel JA, Epstein AE, Ledingham R, Reiter MJ, Yao Q, Duff HJ, Follmann D, Schron E, Greene HL, Carlson MD, Brodsky MQA, Akiyama T, Baessler C, Anderson JL and the AVID Investigators: Beta-Blocker Use and Survival in Patients with Ventricular Fibrillation or Symptomatic Ventricular Tachycardia: The Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. J Am Coll Cardiol, 1999;34:325-333.

Pacifico A, Ferlic LL, Cedillo-Salazar F, Nasir N Jr, Doyle TK, Henry PD. Shocks as Predictors of Survival in Patients with Implantable Cardioverter-Defibrillators. JACC, 1999;34:204-210.

Pacifico A, Hohnloser SH, Williams JH, Tao B, Saksena S, Henry PD, Prystowsky EN for the d,I-Sotalol Implantable Cardioverter-Defibrillator Study Group: Prevention of Implantable Defibrillator Shocks by Treatment with Sotalol. NEJM, 1999;340:1855-1862.

Olshansky B, Hahn EA, Hartz VL, Prater SP, Mason JW and the ESVEM Investigators: Clinical Significance of Syncope in the Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) Trial. Am Heart J, 1999;137:878-886.

Anderson JL, Hallstrom AP, Epstein AE, Pinski SL, Rosenberg Y, Nora MO, Chilson D, Cannom DS, Moore R and the AVID Investigators: Design and Results of the Antiarrhythmic vs Implantable Defibrillators (AVID) Registry. Circulation, 1999;99:1692-1699.

Shusterman V, Benhur A, Gottipaty V, Weiss R, Brode S, Schwartzman D, Anderson KP for the ESVEM Investigators: Autonomic Nervous System Activity and the Spontaneous Initiation of Ventricular Tachycardia. J Am Coll Cardiol, 1998;32:1891-1899.

Brooks MM, Jenkins LS, Schron EB, Steinberg JS, Cross JA, Paeth DS for the AVID Investigators: Quality of Life at Baseline: Is Assessment After Randomization Valid? Med Care, 1998;36:1515-1519.

Natale A, Sra J, Akhtar M, Kusmirek L, Tomassoni G, Leonelli F, Newby K, Beheiry, Pacifico A: Use of Sublingual Nitroglycerin During Head-Up Tilt-Table Testing in Patients >60 Years of Age. Am J Cardiol, 1998;82:1210-1213.

Pacifico A, Johnson JW, Stanton MS, Steinhaus DM, Gabler R, Church T, Henry PD for the Jewel 7219D Investigators: Comparison of Results in Two Implantable Defibrillators. Am J Cardiol, 1998;82:875-880.

Nevels RD, Arndt GD, Raffoul GW, Carl JR, Pacifico A: Microwave Catheter Design. IEEE Trans Biomed Eng, 1998;45:885-890.

Henry PD and Pacifico A: Altering Molecular Mechanisms to Prevent Sudden Arrhythmic Death. Lancet, 1998;351:1276-1278.

Flaker GG, Tummala R, Wilson J for World Wide Jewel Investigators: Comparison of Right- and Left-Sided Pectoral Implantation Parameters with the Jewel Active Can Cardiodefibrillator. PACE, 1998;21:447-451.

Pacifico A and Henry PD: Working Toward an Efficient Electrophysiology Practice. Cardiac Electrophys Review, 1998;2:91-93.

Henry PD and Pacifico A: Sudden Cardiac Death: Still More Questions Than Answers. G Ital Cardiol, 1997;27:1319-1324.

The AVID Investigators: A Comparison of Antiarrhythmic Drug Therapy With Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias. NEJM, 1997;337:1576-1583.

The Atrial Fibrillation Investigation with Bidisomide (AFIB) Investigators: Treatment of Atrial Fibrillation and Paroxysmal Supraventricular Tachycardia with Bidisomide. Circulation, 1997;96:2625-2632.

Caruso AC, Marcus FI, Hahn EA, Hartz VL, Mason JW and the ESVEM Investigators: Predictors of Arrhythmic Death and Cardiac Arrest in the ESVEM Trial. Circulation, 1997;96: 1888-1892.

Kim SG, Hallstrom A, Love JC, Rosenberg Y, Powell J, Roth J, Brodsky M, Moore R, Wilkoff B for the AVID Investigators: Comparison of Clinical Characteristics and Frequency of Implantable Defibrillator Use Between Randomized Patients in the Antiarrhythmics Vs. Implantable Defibrillators (AVID) Trial and Nonrandomized Registry Patients. Am J Cardiol, 1997;80:454-457.

Pacifico A, Cedillo-Salazar FR, Nasir N Jr, Doyle TK, Henry PD: Conscious Sedation With Combined Hypnotic Agents for Implantation of Implantable Cardioverter-Defibrillators. JACC, 1997;30:769-73.

Natale A, Sra J, Geiger MJ, Newby K, Akhtar M, Pacifico A: Right-Side Implant of the Unipolar Single Lead Defibrillation System. PACE, 1997;20[Pt.I]:1910-1912.

Domanski MJ, Saksena S, Wyse G, Hallstrom A, Schron EB, Nanda A, Kutalek S and the AVID Investigators: Clinical and Socioeconomic Profile of Patients with Malignant Ventricular Arrhythmias in 1993 to 1995. Am J Cardiol, 1997;80:299-301.

Arndt GD, Carl JR, Raffoul GW, Karasack VG, Piper CF, Pacifico A: Microwave Treatment of Cardiac Arrhythmias. Tech Briefs, 1997;21:80-82.

Nasir N Jr, Cedillo-Salazar FR, Doyle TK, Henry PD, Pacifico A: Effect of Preexisting Epicardial Patch Electrodes on Defibrillation Thresholds of Unipolar Defibrillators. Am J Cardiol, 1997;79:1408-1409.

Curtis AB, Hallstrom AP, Klein RC, Nath S, Pinski SL, Epstein AE, Wyse DG, Cannom DS, Renfroe E and the AVID Investigators: Influence of Patient Characteristics in the Selection of Patients for Defibrillator Implantation (The AVID Registry). Am J Cardiol, 1997;79:1185-1189.

Reiffel JA, Hahn E, Hartz V, Reiter MJ for the ESVEM Investigators: Sotalol for Ventricular Tachyarrhythmias: Beta-Blocking and Class III Contributions, and Relative Efficacy Versus Class I Drugs After Prior Drug Failure. Am J Cardiol, 1997;79:1048-1053.

Nasir N Jr, Pacifico A, Doyle TK, Earle NR, Hardage ML, Henry PD and the Cadence Investigators: Spontaneous Ventricular Tachycardia Treated by Antitachycardia Pacing. Am J Cardiol, 1997;79:820-822.

Pacifico A: Review of Podrid PJ and Kowey PK, ed., Handbook of Cardiac Arrhythmia. Circulation, 1997;95:757.

Pacifico A, Wheelan KR, Nasir N Jr, Wells PJ, Doyle TK, Johnson SA, Henry PD: Long-Term Follow-Up of Cardioverter-Defibrillator Implanted Under Conscious Sedation in Prepectoral Subfascial Position. Circulation, 1997;95:946-950.

Reiter MJ, Karagounis LA, Mann DE, Reiffel JA, Hahn E, Hartz V and the ESVEM Investigators: Reproducibility of Drug Efficacy Predictions by Holter Monitoring in the Electrophysiographic Monitoring (ESVEM) Trial. Am J Cardiol, 1997;79:315-322.

Bardy GH, Yee R, Jung W for the Active Can Investigators: Multicenter Experience With a Pectoral Unipolar Implantable Cardioverter-Defibrillator. J Am Coll Cardiol, 1996;28:400-410.

Zaim S, Zaim B, Rottman J, Mendoza I, Nasir N Jr, Pacifico A: Characterization of Spontaneous Recurrent Ventricular Arrhythmias Detected by Electrogram-Storing Defibrillators in Sudden Cardiac Death Survivors with No Inducible Ventricular Arrhythmias at Baseline Electrophysiologic Testing. Amer Heart J, 1996;132:274-279.

Güldal M, Karaoguz R, Pacifico A, Lawrie GM, Akyol T: Undersensing of the Tiny QRS Complexes That Emerged After the Isolation of the Right Ventricle in a Patient with Ventricular Tachycardia. PACE, 1996;19:868-871.

Nasir N Jr, Swarna US, Boahene KA, Doyle TK, Pacifico A: Therapy of Sustained Ventricular Arrhythmias with Amiodarone: Prediction of Efficacy with Serial Electrophysiologic Studies. J Cardiovasc Pharmacol Therapeut, 1996;I:123-132.

Leonelli FM, Dunn JK, Young JB, Pacifico A: Natural History, Determinants, and Clinical Relevance of Conduction Abnormalities Following Orthotopic Heart Transplantation. Am J Cardiol, 1996;77:47-51.

Levine JH, Massumi A, Scheinman MM, Winkle RA, Platia EV, Chilson DA, Gomes JA, Woosley RL for the Intravenous Amiodarone Multicenter Trial Group: Intravenous Amiodarone for Recurrent Sustained Hypotensive Ventricular Tachyarrhythmias. J Am Coll Cardiol, 1996;27: 67-75.

Natale A, Sra J, Axtell K, Akhtar M, Newby K, Kent V, Brandon MJ, Kearney MM, Pacifico A: Undetected Ventricular Fibrillation in Transvenous Implantable Cardioverter Defibrillator: Prospective Comparison of Different Lead System-Device Combinations. Circulation, 1996;93:91-98.

Scheinman MM, Levine JH, Cannom DS, Friehling TD, Kopelman HA, Chilson DA, Platia EV, Wilber DJ, Kowey PR for the Intravenous Amiodarone Multicenter Investigators Group: Dose-Ranging Study of Intravenous Amiodarone in Patients with Life-Threatening Ventricular Tachyarrhythmias. Circulation, 1995;92:3264-3272.

Kowey PR, Levine JH, Herre JM, Pacifico A, Linsay BD, Plumb VJ, Janosik DL, Kopelman HA, Scheinman MM for the Intravenous Amiodarone Multicenter Investigators Group: Randomized, Double-Blind Comparison of Intravenous Amiodarone and Bretylium in the Treatment of Patients with Recurrent, Hemodynamically Destabilizing Ventricular Tachycardia or Fibrillation. Circulation, 1995;92:3255-3263.

Tokgozoglu LS, Ashizawa T, Pacifico A, Armstrong RM, Epstein HF, Zoghbi A: Cardiac Involvement in a Large Kindred with Myotonic Dystrophy: Quantitative Assessment and Relation to Expansion of CTG Repeats. JAMA, 1995;274:813-819.

Anderson KP, Walker R, Dustman T, Fuller M, Mori M for the ESVEM Investigators: Spontaneous Sustained Ventricular Tachycardia in the Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) Trial. J Am Coll Cardiol, 1995;26:489-96.

Reiter MJ, Mann DE, Reiffel JE, Hahn E, Hartz V and the ESVEM Investigators: Significance and Incidence of Concordance of Drug Efficacy Predictions by Holter Monitoring and Electrophysiological Study in the ESVEM Trial. Circulation, 1995;91:1988-1995.

Wood MA, Stambler BS, Damiano RJ, Greenway P, Ellenbogen KA, and The Guardian ATP 4210 Multicenter Investigators Group: Lessons Learned From Data Logging in a Multicenter Clinical Trial Using a Late-Generation Implantable Cardioverter-Defibrillator. J Am Coll Cardiol, 1994:24:1692-1699.

Omoigui NA, Marcus FI, Mason JW, Hahn EA, Hartz VL, Hlatky MA for the ESVEM Investigators: Cost of Initial Therapy in the Electrophysiologic Study Versus ECG Monitoring Trial (ESVEM). Circulation, 1995;91:1070-1076.

The AVID Investigators: Antiarrhythmics Versus Implantable Defibrillators (AVID)-- Rationale, Design, and Methods. Amer J Cardiol, 1995;75:470-475.

Lehmann MH, Thomas A, Nabih M, Steinman RT, Fromm BS, Shah M, Norsted SW and Participating Investigators: Sudden Death in Recipients of First-Generation Implantable Cardioverter-Defibrillators: Analysis of Terminal Events. J Interven Cardiol, 1994;7:487-50.

Pieper CF, Pacifico A: Improved Spatial Resolution for Cardiac Mapping Using Current Source Density Electrode Arrays. PACE, 1995;18:34-44.

Nasir N Jr, Taylor A, Doyle TK and Pacifico A: Evaluation of Intravenous Lidocaine for the Termination of Sustained Monomorphic Ventricular Tachycardia in Patients with Coronary Artery Disease With or Without Healed Myocardial Infarction. Amer J Card, 1994:74:1183-1186.

Reiter MJ, Fain ES, Senelly KM, Robertson AD and the Cadence Investigators: Predictors of Device Activation for Ventricular Arrhythmias and Survival in Patients with Implantable Pacemakers/Defibrillators. PACE, 1994;17:1487-1498.

Langston MA, Pieper CF, Pacifico A: Spectral Analysis of Activation Time Sequences. PACE, 1994;17:1288-1299.

Nasir N Jr, Doyle TK, Wheeler SH, Pacifico A: Usefulness of Holter Monitoring in Predicting Efficacy of Amiodarone Therapy for Sustained Ventricular Tachycardia Associated with Coronary Artery Disease. Amer J Cardiol, 1994;73:554-558.

Leonelli FM, Pacifico A, Young JB: Frequency and Significance of Conduction Defects Early After Orthotopic Heart Transplantation. Amer J Cardiol, 1994;73:175-179.

Stambler BS, Wood MA, Damiano RJ, Greenway PS, Smutka ML, Ellenbogen KA, Guardian ATP 4210 Multicenter Investigators: Sensing/Pacing Lead Complications With a Newer Generation Implantable Cardioverter-Defibrillator: Worldwide Experience from the Guardian ATP 4210 Clinical Trial. JACC, 1994;23:123-132.

Sager PT, Nademanee K, Antimisiaris M, Pacifico A, Pruitt C, Godfrey R, Singh BN: Antiarrhythmic Effects of Selective Prolongation of Refractoriness: Electrophysiologic Actions of Sematilide HCL in Humans. Circulation, 1993;88:1072-1082.

Mason JW, the ESVEM Investigators: A Comparison of Seven Antiarrhythmic Drugs in Patients with Ventricular Tachyarrhythmias. NEJM, 1993;329:452-459.

Mason JW, the ESVEM Investigators: A Comparison of Electrophysiologic Testing with Holter Monitoring to Predict Antiarrhythmic-Drug Efficacy for Ventricular Tachyarrhythmias. NEJM, 1993;329:445-451.

Pieper CF, Pacifico A: The Epicardial Field Potential in Dog: Implications for Recording Site Density During Epicardial Mapping. PACE, 1993;16:1263-1274.

Pieper CF, Blue R, Pacifico A: Simultaneously Collected Monopolar and Discrete Bipolar Electrograms: Comparison of Activation Time Detection Algorithms. PACE, 1993;16:426-433.

The ESVEM Investigators: Determinants of Predicted Efficacy of Antiarrhythmic Drugs in the Electrophysiologic Study Versus Electrocardiographic Monitoring Trial. Circulation, 1993;87:323-329.

Pieper CF, Pacifico A: Observations on the Epicardial Activation of the Normal Human Heart. PACE, 1992;15:2295-2307.

Saksena S, Poczobutt-Johanos M, Castle L, Fogoros R, Alpert B, Kron J, Pacifico A, Griffin J, Ruskin J, Kehoe RF, Yee R, Dorian P, Kerr CR, Luceri R, Poliseno M: Long-Term Multicenter Experience With A Second-Generation Implantable Pacemaker-Defibrillator in Patients With Malignant Ventricular Tachyarrhythmias. J Am Coll Cardiol, 1992;19:490-499.

Pieper CF, Blue R, Pacifico A: Influence of Time of Sampling Onset on Parameters Used for Activation Time Determination in Computerized Intraoperative Mapping. PACE, 1991; 14:2187-2192.

Pieper CF, Blue R, Pacifico A: Activation Time Detection Algorithms Used in Computerized Intraoperative Cardiac Mapping: A Comparison with Manually Determined Activation Times. J Cardiovasc Electrophysiol, 1991;2:388-397.

O'Neill PG, Faitelson L, Taylor A, Puleo P, Roberts R, Pacifico A: Time Course of Creatinine Kinase Release Following Termination of Sustained Ventricular Dysrhythmias. Am Heart J, 1991;122(3):709-714.

Pieper CF, Blue R, Pacifico A: Activation Time Detection Algorithms Used in Computerized Intraoperative Cardiac Mapping: A Comparison with Manually Determined Activation Times. J Cardiovasc Electrophysiol, 1991;2:388-397.

O'Neill PG, Faitelson L, Taylor A, Puleo P, Roberts R, Pacifico A: Time Course of Creatinine Kinase Release Following Termination of Sustained Ventricular Dysrhythmias. Am Heart J, 1991;122(3):709-714.

Pieper CF, Parsons D, Lawrie GM, Lacy J, Roberts R, Pacifico A: Design and Implementation of New Computerized System for Intraoperative Cardiac Mapping: Experience During Surgery. J Appl Physiol, 1991;71:1529-1539.

O'Neill PG, Rokey R, Greenberg S, Pacifico A: Endocardial Tuberculoma Following Antituberculous Therapy. CHEST, 1991;100:1467-1469.

Kotliar C, Smart FW, Sekala ME, Pacifico A, Pratt CM, Noon GP, DeBakey ME, Young JB: Relationship of Heterotopic Transplantation to Native Heart Ventricular Arrhythmias. Ann Thorac Surg, 1991;51:987-91.

Freedman FA, Steinnerg JS, the ESVEM Investigators: Selective Prolongation of Late Potentials by Sodium-Channel Blocking Antiarrhythmic Drugs: Relation to Slowing of Ventricular Tachycardia. J Am Coll Cardiol, 1991;17(5):1017-1025.

Lawrie GM, Pacifico A: Surgery for Ventricular Tachycardia. J Cardiovasc Electrophysiol, 1991;2:65.

O'Neill PG, Lawrie GM, Kaushik R, Harville LF, Pacifico A: Late Results of the Left Subcostal Approach for Automatic Implantable Cardioverter Defibrillator Implantation. Am J Cardiol, 1991;67:387.

O'Neill PG, Boahene KA, Lawrie GM, Howell LF, Pacifico A: The Effect of Patch Polarity on Defibrillation Thresholds. J Am Coll Cardiol, 1991;17:707.

Pieper CF, Lawrie GM, Roberts R, Pacifico A: Bandwidth Induced Errors in Parameters Used for Automated Activation Time Determination During Computerized Intraoperative Cardiac Mapping: Theoretical Limits. PACE, 1991;14:214.

Lawrie GM, Pacifico A, Kaushik R, Nahas C, Earle N: Factors Predictive of Results of Direct Ablative Surgery for Drug-Refractory Ventricular Tachycardia: Analysis of 80 Patients. J Thorac Cardiovasc Surg, 1991;101:44.

Pieper C, Lawrie GM, Parsons D, Lacy J, Roberts R, Pacifico A: Experience with Kapton Based Bipolar Electrode Arrays Used During Intraoperative Computerized Mapping. J Cardiovasc Electrophysiol, 1990;1:496.

Adenosine for PSVT Study Group: Adenosine for Paroxysmal Supraventricular Tachycardia Dose-Ranging and Comparison with Verapamil. Ann of Int Med, 1990;113:104.

O'Neill PG, Menendez T, Hust R, Howell J, Espada R, Pacifico A: Prolonged Ventricular Fibrillation-Salvage Using A New Percutaneous Cardiopulmonary Support System. Am J Cardiol, 1989;64:545.

Lawrie GM, Pacifico A, Kaushik R: Transannular Cryoablation of Ventricular Tachycardia. J Thor Cardiovasc Surg, 1989;98:1030.

Lawrie GM, Pacifico A: The Role of Surgery in the Treatment of Tachyarrhythmias. Int J Cardiol, 1989;25:151.

The ESVEM Investigators: The ESVEM Trial: Electrophysiology Study Versus Electrocardiographic Monitoring for Selection of Antiarrhythmic Therapy of Ventricular Tachyarrhythmias. Circulation, 1989;79:1354.

Lawrie GM, Pacifico A, Kaushik R: Results of Direct Surgical Ablation of Ventricular Tachycardia Not Due to Ischemic Heart Disease. Ann Surg, 1989;290:713.

Lawrie GM, Kaushik R, Pacifico A: Right Mini-Thoracotomy: An Adjunct to Left Subcostal AICD Implantation. Ann Thorac Surg, 1989;47:780.

Pacifico A: Non-Pharmacological Treatment of Cardiac Arrhythmias: Use of Pacemakers, Theoretical Consideration, Technical Aspects, and Indication. Problems in Critical Care, 1988;2:402-420.

Pratt CM, Francis M, Eaton T, Pacifico A: Ambulatory ECG Recordings. Current Problems in Cardiology, 1988;8:521.

Seals AA, Lawrie GM, Magro S, Lin HT, Pacifico A, Roberts R, Wyndham CRC: Surgical Treatment of Atrial Focal Tachycardia in Adults. J Am Coll Cardiol, 1988;11:1111-7.

Ugolini V, Pacifico A, Smitherman TC, Mackowiack PA: Pneumococcal Endocarditis Update. Am Heart J, 1986;112(4):813-19.

Van Den Berg E, Pacifico A, Lange RA, Wheelan KR, Winniford MD, Hillis LD: Measurement of Cardiac Output Without Right Heart Catheterization: Reliability, Advantages, and Limitations of A Left-Sided Indicator Dilution Technique. Cathet Cardiovasc Diagn, 1986;12(3):205-08.

Goodman JM, Maher JF, Silver PA, Pacifico A, Sanders D: The Membrane Proteins of the Methanol-lnduced Peroxisome of Candida Boidinii. J Biol Chem, 1986;261:464-3468.

Pacifico A, Capra JD: T Cell Hybrids with Arsonate Specificity. I. Initial Characterization of Antigen-Specific T Cell Products That Bear A Cross-Reactive Idiotype and Determinants Encoded by the Murine Major Histocompatibility Complex. J Exp Med, 1980;152:1289-1301.

Pacifico A, Serra P: Attualita' in Tema Di Cancro Del Polmone. II Policlinico-Sezione Pratica, 1978;85:1-6.

Pacifico A, Serra P: Su Alcuni Aspetti Patogenetici Dell'Endocardite Infettiva. II Policlinico-Sezione Pratica, 1977;84:222-226.